Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta variable 11-1 (TRBV11-1) is a germline-encoded variable gene segment of the T cell receptor beta chain locus. It encodes part of the variable domain of the T cell receptor (TCR) beta chain, which, together with an alpha chain, forms the antigen-binding site of the TCR expressed on the surface of T lymphocytes. The TRBV11-1 segment contributes to the diversity of the TCR repertoire, enabling recognition of a broad range of peptide antigens presented by major histocompatibility complex (MHC) molecules. Skewed usage or monoclonal expansion of TRBV11-1 has been observed in various immune responses, including viral infections and cancer, but TRBV11-1 itself is not independently druggable. It is important as a biomarker for disease monitoring and immune status analysis, rather than as a direct therapeutic target. TRBV11-1 is not a unique protein but part of the somatic recombination process generating variable regions of TCRs. It functions through inclusion in a mature TCR, essential for T cell antigen specificity and immune response. Significant in immune repertoire skewing, possibly as a marker in infection (e.g. hepatitis B) and immune profiling. No known drugs directly interact with, or target, the TRBV11-1 gene segment or its product. When reporting or structuring information, refer to the genomic forename "T cell receptor beta variable 11-1," using abbreviation "TRBV11-1."
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 11-1 (TRBV11-1).